Macrogenics Inc (NASDAQ: MGNX) is -62.14% lower on its value in year-to-date trading and has touched a low of $0.99 and a high of $5.77 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The MGNX stock was last observed hovering at around $1.47 in the last trading session, with the day’s gains setting it 0.12%.
Currently trading at $1.59, the stock is 12.49% and 6.44% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.3 million and changing 8.16% at the moment leaves the stock -37.77% off its SMA200. MGNX registered -51.08% loss for a year compared to 6-month loss of -54.05%. The firm has a 50-day simple moving average (SMA 50) of $1.4938 and a 200-day simple moving average (SMA200) of $2.5549.
The stock witnessed a -10.67% gain in the last 1 month and extending the period to 3 months gives it a 44.55%, and is 26.19% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.05% over the week and 9.87% over the month.
Macrogenics Inc (MGNX) has around 341 employees, a market worth around $100.31M and $154.05M in sales. Profit margin for the company is -36.23%. Distance from 52-week low is 60.66% and -72.44% from its 52-week high. The company has generated returns on investments over the last 12 months (-50.18%).
The EPS is expected to shrink by -55.61% this year
168.0 institutions hold shares in Macrogenics Inc (MGNX), with institutional investors hold 76.14% of the company’s shares. The shares outstanding are 63.09M, and float is at 57.94M with Short Float at 9.55%. Institutions hold 73.84% of the Float.
The top institutional shareholder in the company is BELLEVUE GROUP AG with over 9.94 million shares valued at $42.25 million. The investor’s holdings represent 15.8662 of the MGNX Shares outstanding. As of 2024-06-30, the second largest holder is ARMISTICE CAPITAL, LLC with 6.0 million shares valued at $25.5 million to account for 9.5749 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 5.4 million shares representing 8.6202 and valued at over $22.96 million, while VANGUARD GROUP INC holds 6.5992 of the shares totaling 4.14 million with a market value of $17.58 million.
Macrogenics Inc (MGNX) Insider Activity
The most recent transaction is an insider sale by Smith Beth Ann, the company’s VP, Controller & Treasurer. SEC filings show that Smith Beth Ann sold 423 shares of the company’s common stock on Feb 15 ’25 at a price of $2.56 per share for a total of $1083.0. Following the sale, the insider now owns 9532.0 shares.
